Slavomira Gulova

Ms. Slavomira Gulova

University of Pavol Jozef Šafárik, Košice, Košický, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DHDenisa Harvanova
Denisa Harvanova
JMJana Matejova
Jana Matejova
LSLucia Slovinská
Lucia Slovinská
MLMarek Lacko
Marek Lacko
SGSlavomira Gulova
Slavomira Gulova
JRJan Rosocha
Jan Rosocha
There is a lack of in vitro models able to plausibly represent the inflammation microenvironment of knee osteoarthritis (OA). We analyzed the molecules released from OA tissues (synovial membrane, cartilage, infrapatellar fat pad) and investigated whether the stimulation of human synovial fibroblasts (SFs), with synthetic cytokines (IL-1β and TNF-α or IFN-γ) or conditioned media (CM) from OA tissues, influence the SFs’ response, in the sense of pro-inflammatory cytokines, chemokines, growth factors, and degradative enzymes modulation. Human SFs were obtained from OA synovial membranes. SFs and their CM were analyzed for biomarkers, proliferation rate, protein profile and gene expression, before and after stimulation. Real-time PCR and multiplex assays quantified OA-related gene expression and biomolecule production. Unlike other activators, CM from OA synovial membrane (CM-SM), significantly up-regulated all genes of interest (IL-6, IL-8, MMP-1, MMP-3, RANTES, MCP-1, TSG-6, YKL-40) in SFs. Multiplex immunoassay analysis showed that levels of OA-related cytokines (IL-6, IL-8, MCP 1, IL-1Ra), chemokine (RANTES) and growth factor (VEGF), produced by CM-SM stimulated SFs, increased significantly compared to non-stimulated SFs. Molecules released from the SM from OA patients induces OA-like changes in vitro, in specific OA synovial populations (SFs). These findings promote the use and establish a compelling in vitro model that simulates the versatility and complexity of the OA disease. This model, in the future, will allow us to study new cell therapies or test drugs by reducing or avoiding animal models.

24 October 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SGSlavomira Gulova
Slavomira Gulova
AOAlexander Otahal
Alexander Otahal
KKKarina Kramer
Karina Kramer
MRMarkus Rothammer
Markus Rothammer
ZLZsombor Lacza
Zsombor Lacza
ALAndrea De Luna
Andrea De Luna
Since Hoffa’s fat pad (HFP) is naturally involved in the joint environment, and given findings that HFP-derived mesenchymal stromal cells (MSCs) possess better chondrogenic differentiation capacity than other adipose tissue sources or bone marrow, we aimed to analyze HFP-MSCs derived extracellular vesicles (EVs) primed with blood products as potential cell-free osteoarthritis (OA) therapy. HFP-MSCs were cultured under 3D conditions on microcarriers in vertical-wheel bioreactors. Prior to medium harvest, MSCs were primed with blood products, including fetal calf serum (FCS), platelet-rich plasma (PRP), or hyperacute serum (HypACT). EVs were isolated via ultrafiltration and characterized via cryo-electron microscopy, nanoparticle tracking analysis (NTA) in both scatter and fluorescence modes, as well as via Western blot (WB). CFSE-labeled EV internalization by chondrocytes and synovial fibroblasts was detected using fluorescent confocal microscopy in the presence or absence of polybrene. Polybrene was used to enhance EV internalization and potentially improve treatment efficacy in cells. To simulate an OA environment, chondrocytes and synovial fibroblasts were co-cultured with M1 macrophages. Gene expression changes were analyzed via RT-qPCR, while cytokine release was quantified using ELISA. HFP-MSC-EVs downregulated the expression of catabolic enzyme genes MMP3 and MMP13 in chondrocytes, as well as the inflammatory genes CCL5 and COX2 in synovial fibroblasts. COL2A gene expression was upregulated in chondrocytes treated with HFP-MSC-EVs from a young donor. Furthermore, HFP-MSC-EVs elevated the release of the anti-inflammatory cytokine IL-10 from chondrocyte and synovial fibroblast co-cultured with M1 macrophages. HFP-MSC-EVs also upregulated IL10 gene expression in M1 macrophages. Polybrene significantly enhanced the internalization of HFP-MSC-EVs by chondrocytes and synovial fibroblasts, but did not improve treatment efficacy. HFP-MSC-EVs may have therapeutic potential mediated by attenuating inflammation and downregulation of catabolic enzymes in cells critical to OA progression.